Affiliation:
1. Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Yangtze University
2. Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei Province, China
Abstract
The development of chemo-resistance in nasopharyngeal carcinoma (NPC) presents a significant therapeutic challenge, and its underlying mechanisms remain poorly understood. In our previous studies, we highlighted the association between isoprenylcysteine carboxylmethyltransferase (ICMT) and chemoresistance in NPC. In this current research, we revealed that both 5-FU and cisplatin-resistant NPC cells exhibited elevated mitochondrial function and increased expression of mitochondrial genes, independent of ICMT. Our investigations further showed that classic mitochondrial inhibitors, such as oligomycin, antimycin, and rotenone, were notably more effective in reducing viability in chemo-resistant NPC cells compared to parental cells. Moreover, we identified two antimicrobial drugs, tigecycline and atovaquone, recognized as mitochondrial inhibitors, as potent agents for decreasing chemo-resistant NPC cells by targeting mitochondrial respiration. Remarkably, tigecycline and atovaquone, administered at tolerable doses, inhibited chemo-resistant NPC growth in mouse models and extended overall survival rates. This work unveils the efficacy of mitochondrial inhibition as a promising strategy to overcome chemo-resistance in NPC. Additionally, our findings highlight the potential repurposing of clinically available drugs like tigecycline and atovaquone for treating NPC patients who develop chemoresistance.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference28 articles.
1. Nasopharyngeal carcinoma a ‘different’ head and neck tumour Part A: from histology to staging.;Cantu;Acta Otorhinolaryngol Ital,2023
2. Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma.;Zhu;Front Oncol,1259
3. Precision drugs for recurrent or metastatic nasopharyngeal carcinoma (Review).;Liang;Exp Ther Med,2023
4. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.;Zhu;Biochem Biophys Res Commun,2019
5. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma.;Guan;Eur J Med Chem,1127